More potent linear peptide inhibitors of mammalian ribonucleotide reductase
Chiheng Tan1, Ying Gao, Jaskiran Kaur
1Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.
Abstract:
Mammalian ribonucleotide reductase (mRR) is a chemotherapeutic target. The enzyme is composed of two subunits (mR1 and mR2) and is inhibited by Ac-FTLDADF (denoted P7), corresponding to the C-terminus of mR2, which disrupts mRR quaternary structure by competing with mR2 for binding to mR1. The tripeptide FmocWFF acts similarly. Here we report on the use of small, focused libraries to identify Fmoc derivatives of tetra and hexapeptides having comparable or considerably higher activities than P7 toward inhibition of mRR.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Inhibitors of Bacterial DNA Synthesis
Ribozymes
Ribozymes can be...
Inhibitors of Viral Protein Synthesis
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

